BTIG Initiates Coverage On DarioHealth with Buy Rating, Announces Price Target of $6
Benzinga Newsdesk 4 days ago
Analyst RatingsNewsInitiationPrice Target
BTIG analyst David Larsen initiates coverage on DarioHealth (NASDAQ:DRIO) with a Buy rating and announces Price Target of $6.
BTIG analyst David Larsen initiates coverage on DarioHealth (NASDAQ:DRIO) with a Buy rating and announces Price Target of $6.